Hodgkin Lymphoma (b-cell Hodgkin Lymphoma) Clinical Trial Anaylsis By Trial Phase, Trial Status,
January 27, 2023 ⚊ 1 Min read ⚊ Views 62 ⚊ TECHNOLOGY
The Hodgkin Lymphoma clinical trials market is the largest in North America, followed by Europe, Asia Pacific, the Middle East and Africa, and South and Central America. In a country-wise analysis, as of May 2022, the US has the highest number of Hodgkin Lymphoma clinical trials, followed by Italy, Germany, France, Canada, China, the UK, Australia, Spain, and Netherlands. Netherlands has the highest average patient enrollment in Hodgkin Lymphoma clinical trials.
G7 countries:
Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the United States have the highest proportion of Hodgkin Lymphoma to oncology clinical trials. Moreover, out of all the clinical trials conducted in the G7 countries, the majority were in the US.
